Sean Ellis
CIK: 0001904752
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Entera Bio Ltd.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 7, 2026ENTX
Entera Bio Ltd.
Award(A)Direct20K shares- - Mar 5, 2026ENTX
Entera Bio Ltd.
Purchase(P)Direct10K shares at avg. $1.23$12K - Feb 9, 2026ENTX
Entera Bio Ltd.
Purchase(P)Direct18K shares at avg. $1.24$22K - Jan 1, 2026ENTX
Entera Bio Ltd.
Award(A)Direct25.4K shares- - Jan 15, 2025ENTX
Entera Bio Ltd.
Award(A)Direct7.1K shares- - Oct 2, 2024ENTX
Entera Bio Ltd.
Award(A)Direct7.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 7, 2026 | ENTX Entera Bio Ltd. | Award(A) | 20,034 | - | $0 | Direct |
| Mar 5, 2026 | ENTX Entera Bio Ltd. | Purchase(P) | 10,000 | $1.23 | $12,300 | Direct |
| Feb 9, 2026 | ENTX Entera Bio Ltd. | Purchase(P) | 18,000 | $1.24 | $22,320 | Direct |
| Jan 1, 2026 | ENTX Entera Bio Ltd. | Award(A) | 25,371 | - | $0 | Direct |
| Jan 15, 2025 | ENTX Entera Bio Ltd. | Award(A) | 7,100 | - | $0 | Direct |
| Oct 2, 2024 | ENTX Entera Bio Ltd. | Award(A) | 7,466 | - | $0 | Direct |
1-6 of 6 transactions
About Ellis Sean
Ellis Sean (SEC CIK 0001904752) files insider reports with the SEC as Director of Entera Bio Ltd. (ENTX).
Signal8 holds 6 ownership filings by Ellis Sean, all Form 4s, filed between Oct 4, 2024 and Aug 7, 2026. Those filings report 6 transactions, from Oct 2, 2024 to Aug 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ellis Sean's filings is in JERUSALEM.
Recent filings by Ellis Sean
- Aug 7, 2026: Grant or award of ENTX shares (Form 4, code A).
- Mar 5, 2026: Open-market purchase of ENTX shares (Form 4, code P).
- Feb 9, 2026: Open-market purchase of ENTX shares (Form 4, code P).
- Jan 1, 2026: Grant or award of ENTX shares (Form 4, code A).
- Jan 15, 2025: Grant or award of ENTX shares (Form 4, code A).
Other insiders filing for Entera Bio Ltd. (ENTX)
- Camisasca Riccardo Paolo, Chief Medical Officer
- Malca Yonatan, Director
- Taitel Haya, Director
- Yaacov-Garbeli Dana, Chief Financial Officer
- Galitzer Hillel, Chief Operating Officer
- Burshtein Gregory, Chief of R&D